TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26382936

Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 scores for patients with no visual impairment (mean 73 ± 22)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Visual acuity (VA) and visual field index (VFI)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: VFI worse than 50% or mean deviation (MD) worse than -18 dB
Number of subjects: 255
Study: 23856279

Group type: EXPERIMENTAL
Intervention: Aerobic training intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Exercise control intervention
Number of subjects: 111
Study: 21282537

Group type: EXPERIMENTAL
Intervention: Vandetanib 100 mg/d plus pemetrexed 500 mg/m² every 21 days
Number of subjects: 534

Group type: COMPARATOR
Intervention: Placebo plus pemetrexed
Number of subjects: 534
Study: 20053324

Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 0
Study: 16859122

Group type: EXPERIMENTAL
Intervention: Chemoembolization of bilateral internal iliac arteries with anticancer agents and gelatin sponge particles during Miles operation
Number of subjects: 113

Group type: COMPARATOR
Intervention: Miles operation (control group)
Number of subjects: 113
Study: 15105193

Group type: EXPERIMENTAL
Intervention: Automated cardiac output measurement (ACOM)
Number of subjects: 36
Study: 12108093

Group type: EXPERIMENTAL
Intervention: Meropenem 1 g i.v. every 8 hours
Number of subjects: 140

Group type: COMPARATOR
Intervention: Ceftazidime 2 g i.v. every 8 hours plus Amikacin 15 mg/kg daily
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 140

Group type: COMPARATOR
Intervention: Ceftazidime/Amikacin
Number of subjects: 140
Study: 9553664

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (PC group), five two-hour sessions per week for two weeks, repeated after a five-week interval
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 80
Study: 8039271

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg, i.v. bolus)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Naloxone (125 micrograms/kg bodyweight, i.v. bolus)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Naloxone (125 micrograms/kg bodyweight, i.v. bolus) with Flumazenil
Number of subjects: 9
Study: 2690315

Group type: EXPERIMENTAL
Intervention: C-terminal octapeptide of human oxyntomodulin (KA-8) 7.5 nmol/kg body weight
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 4606788

Group type: EXPERIMENTAL
Intervention: Farm families matched with their own livestock
Number of subjects: 14

Group type: COMPARATOR
Intervention: Random assortments of farm families and livestock
Number of subjects: 14
Study: 29447581

Group type: EXPERIMENTAL
Intervention: Positive attitudes about the innovation's attributes
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Social pressure created by a descriptive norm
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Descriptive norm
Number of subjects: 329
Study: 26743100

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy (PST)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 221
Study: 25615523

Group type: EXPERIMENTAL
Intervention: Evidence-based anxiety intervention (including cognitive behavioral therapy and medications)
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Usual care in primary care
Number of subjects: 1004
Study: 23490311

Group type: EXPERIMENTAL
Intervention: Rehydration rate and fluid sodium content
Number of subjects: 13
Study: 20609741

Group type: EXPERIMENTAL
Intervention: Tight glycemic control (TGC)
Number of subjects: 14
Study: 19572438

Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir (LPV/r)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 155
Study: 16506042

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment (psychological and physical sessions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual care provided by occupational health services
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment
Number of subjects: 38
Study: 14671567

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 2
Study: 10924629

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 8922912

Group type: EXPERIMENTAL
Intervention: Lisinopril treatment for 6 weeks
Number of subjects: 8619

Group type: COMPARATOR
Intervention: Control (no lisinopril)
Number of subjects: 8619
Study: 1416011

Group type: COMPARATOR
Intervention: 0.9% NaCl (group A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.12 mg Cl (group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.24 mg Cl (group C)
Number of subjects: 90
Study: 2860687

Group type: EXPERIMENTAL
Intervention: Nonabine (5, 10, and 15 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketazolam (30 and 45 mg)
Number of subjects: 0
Study: 31051465

Group type: EXPERIMENTAL
Intervention: Semisitting position
Number of subjects: 97

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 97
Study: 29016868

Group type: EXPERIMENTAL
Intervention: Lubiprostone 24 mcg twice daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lubiprostone
Number of subjects: 0
Study: 26806825

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard blood pressure control
Number of subjects: 0
Study: 25351370

Group type: EXPERIMENTAL
Intervention: cDMARDs
Number of subjects: 205

Group type: COMPARATOR
Intervention: TNFis
Number of subjects: 205
Study: 23683993

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 5627

Group type: COMPARATOR
Intervention: Comparator arms (paroxetine, venlafaxine, escitalopram)
Number of subjects: 5627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5627
Study: 20354459

Group type: EXPERIMENTAL
Intervention: Allovectin-7 (2 mg, high dose)
Number of subjects: 133
Study: 19265758

Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 2 Hz
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 26 Hz
Number of subjects: 15
Study: 16030045

Group type: EXPERIMENTAL
Intervention: FX dialyzer
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard high flux dialysis (SHF)
Number of subjects: 35
Study: 14668075

Group type: EXPERIMENTAL
Intervention: bupropion SR (150 or 300 mg) and behavioral counseling (tailored mailings or proactive telephone counseling)
Number of subjects: 1524

Group type: EXPERIMENTAL
Intervention: tailored mailings
Number of subjects: 1524

Group type: EXPERIMENTAL
Intervention: bupropion SR (lower dose)
Number of subjects: 1524

Group type: EXPERIMENTAL
Intervention: lifetime depression
Number of subjects: 1524
Study: 10780310

Group type: EXPERIMENTAL
Intervention: Bemiparin (3,500 anti-Xa IU daily)
Number of subjects: 300

Group type: COMPARATOR
Intervention: UFH (5,000 IU twice daily)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Bemiparin
Number of subjects: 300

Group type: COMPARATOR
Intervention: UFH
Number of subjects: 300
Study: 8639078

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation of extrafoveal and juxtafoveal CNV
Number of subjects: 516
Study: 1521812

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% eye drops, 5 times daily for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prednisolone acetate 1.0% eye drops, 5 times daily for 5 days
Number of subjects: 20
Study: 3511877

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 29889310

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Patients with epilepsy (before treatment)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Patients with epilepsy (after treatment)
Number of subjects: 38
Study: 27647715

Group type: EXPERIMENTAL
Intervention: Baby-Led Introduction to SolidS (BLISS)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 206
Study: 25213665

Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Mindfulness-based task
Number of subjects: 76
Study: 22579817

Group type: EXPERIMENTAL
Intervention: Tryptophan (TrpD) depletion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham depletion
Number of subjects: 28
Study: 21030704

Group type: EXPERIMENTAL
Intervention: Prophylactic endovascular long-term normothermia
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional temperature management (stepwise fever management with antiinflammatory drugs and surface cooling)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drugs (used as additional treatment of fever)
Number of subjects: 102
Study: 15882239

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-start (omeprazole 20 mg daily for 4-8 weeks, then stepped up to omeprazole 40 or 20 mg daily for persistent symptoms)
Number of subjects: 390

Group type: COMPARATOR
Intervention: H2-receptor antagonist-start (ranitidine 150 mg bid for 4-8 weeks, then stepped up to omeprazole for persistent symptoms)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-start
Number of subjects: 390

Group type: COMPARATOR
Intervention: H2-receptor antagonist-start
Number of subjects: 390
Study: 12864764

Group type: EXPERIMENTAL
Intervention: Patented special butterbur root extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10421666

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg orally daily for 12 months
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Lamivudine treatment
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Lamivudine stopped
Number of subjects: 5
Study: 8556545

Group type: EXPERIMENTAL
Intervention: HBV antigens (HBsAg, HBcAg, HBeAg) detected in MN patients
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group of 30 randomly selected MsPGN patients
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Comparison of HBV antigen positivity rates
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Age-related differences in HBV antigen detection
Number of subjects: 67
Study: 2508163

Group type: EXPERIMENTAL
Intervention: Moclobemide (Ro 11‐1163)
Number of subjects: 16
Study: 773584

Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 17
Study: 30212814

Group type: EXPERIMENTAL
Intervention: 4 L of clear liquids (Group A)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: 2 L of PEG (Group B)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: 4 L of PEG (Group C)
Number of subjects: 245
Study: 29101143

Group type: EXPERIMENTAL
Intervention: Operation Smoke Storm (three 50 min classroom-based sessions in year 7, a family booklet, and a 1-hour booster session in year 8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operation Smoke Storm
Number of subjects: 0
Study: 25812845

Group type: EXPERIMENTAL
Intervention: Battery-powered SCDs
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard SCDs
Number of subjects: 67
Study: 24139854

Group type: EXPERIMENTAL
Intervention: Minocycline 200mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 21696353

Group type: EXPERIMENTAL
Intervention: Quick-release bromocriptine (bromocriptine-QR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18431118

Group type: EXPERIMENTAL
Intervention: Part task training (PTT) and variable priority training (VPT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard didactic and simulation-based training
Number of subjects: 22
Study: 16923230

Group type: EXPERIMENTAL
Intervention: Pea-fibre/FOS formula (10 g/l pea-fibre and 5 g/l fructo-oligosaccharides)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 11
Study: 12893078

Group type: EXPERIMENTAL
Intervention: Folic acid 5mg once daily for 1 year
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 20
Study: 10851374

Group type: EXPERIMENTAL
Intervention: Lamotrigine (300 mg per day after titration from 25 mg per day over 7 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 42
Study: 9176537

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8267816

Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (quiet sleep)
Number of subjects: 35
Study: 3711252

Group type: EXPERIMENTAL
Intervention: Annual multiphasic health checkups (MHCs)
Number of subjects: 5156

Group type: COMPARATOR
Intervention: Control group (not urged to have MHCs)
Number of subjects: 5156
Study: 29221643

Group type: EXPERIMENTAL
Intervention: Walking in a traffic-free area (Hyde Park)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Walking down a traffic-polluted road (Oxford Street)
Number of subjects: 119
Study: 29588936

Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct-current stimulation (c-tDCS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 29
Study: 25419887

Group type: EXPERIMENTAL
Intervention: Heatwrap
Number of subjects: 61

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 61
Study: 22588927

Group type: EXPERIMENTAL
Intervention: High-dose ATG-F (30 mg/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low-dose ATG-F (15 mg/kg)
Number of subjects: 64
Study: 20484157

Group type: EXPERIMENTAL
Intervention: E2 supplementation
Number of subjects: 10
Study: 18175750

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose (64 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intraduodenal fat (10% oil emulsion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intraduodenal protein (72 g whey)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intraduodenal saline (0.9%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose, fat, and protein
Number of subjects: 8
Study: 15855288

Group type: EXPERIMENTAL
Intervention: Hi5+ family fruit and vegetable promotion program
Number of subjects: 575
Study: 11839882

Group type: EXPERIMENTAL
Intervention: ICE guided ablation (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional ablation (Group A)
Number of subjects: 40
Study: 10423464

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin plus amoxicillin-clavulanate
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as control for intolerance)
Number of subjects: 116
Study: 7589769

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (500 mg/kg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (nothing given)
Number of subjects: 41
Study: 1979923

Group type: EXPERIMENTAL
Intervention: IV dose of 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV dose of 5 mg to 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV dose
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral dose
Number of subjects: 12
Study: 6928953

Group type: EXPERIMENTAL
Intervention: Reinforced group (Group 3) received a dental health education program with repetition and reinforcement, including two additional visits and a final summary lecture.
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nonreinforced group (Group 2) received one lecture and a toothbrushing lesson without repetition or reinforcement.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (Group I) received no oral hygiene lectures or instructions until the conclusion of the experiment.
Number of subjects: 61
Study: 31574269

Group type: EXPERIMENTAL
Intervention: Animal welfare information
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: Environmental sustainability information
Number of subjects: 1250

Group type: COMPARATOR
Intervention: No information
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Quality information
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Production cost information
Number of subjects: 1250
Study: 31089805

Group type: COMPARATOR
Intervention: 3 in 1 regional pain catheter (C)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Local infiltration anesthesia (L)
Number of subjects: 121
Study: 30174413

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control
Number of subjects: 146
Study: 26855404

Group type: EXPERIMENTAL
Intervention: Mild psychological stress induced by a short mental arithmetic (MA) test
Number of subjects: 5

Group type: COMPARATOR
Intervention: Relaxation period (control)
Number of subjects: 5
Study: 25175985

Group type: EXPERIMENTAL
Intervention: Mental practice (imagining movements of the fractured upper extremity)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirror therapy (performing functional movement synergies using the unaffected forearm, wrist, and hand)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation training (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (including usual care by the general practitioner)
Number of subjects: 0
Study: 21931956

Group type: EXPERIMENTAL
Intervention: Integrated education and counseling intervention to reduce behavioral and psychosocial risks (BPSR)
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Usual care (UCG)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Integrated education and counseling intervention to reduce BPSR
Number of subjects: 1044
Study: 21159375

Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention led by lay health counsellors, supplemented by antidepressant drugs; duration: 6 months
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention in public facilities
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Enhanced usual care in public facilities
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention in private facilities
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Enhanced usual care in private facilities
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1160
Study: 17414601

Group type: EXPERIMENTAL
Intervention: Fibrin glue application
Number of subjects: 300
Study: 16340378

Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12147144

Group type: EXPERIMENTAL
Intervention: Negotiated Telephone Support (NTS) with continued routine management (Group 2)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Negotiated Telephone Support (NTS) with annual clinic (Group 3)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group with continued routine management (Group 1)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 79
Study: 9474309

Group type: EXPERIMENTAL
Intervention: Silicone lens implants
Number of subjects: 64

Group type: COMPARATOR
Intervention: PMMA lens implants
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both lens types
Number of subjects: 64
Study: 7533223

Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg once daily
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg once daily
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combination of moxonidine 0.4 mg and hydrochlorothiazide 25 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 3064779

Group type: EXPERIMENTAL
Intervention: RT + 12 cycles of cyclophosphamide (C)
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: RT + 12 cycles of cyclophosphamide, methotrexate and 5‐fluorouracil (CMF)
Number of subjects: 1028

Group type: COMPARATOR
Intervention: RT alone (control)
Number of subjects: 1028
Study: 28942705

Group type: EXPERIMENTAL
Intervention: Plaster cast removal and immediate mobilization after 10 days
Number of subjects: 109

Group type: COMPARATOR
Intervention: Continued plaster cast fixation for another 3 weeks
Number of subjects: 109
Study: 26508680

Group type: EXPERIMENTAL
Intervention: Levocarnitine therapy (20mg/kg/d for 12 months)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (no levocarnitine therapy)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Levocarnitine therapy
Number of subjects: 222
Study: 24424629

Group type: EXPERIMENTAL
Intervention: 0.5 Gy
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: 1.0 Gy
Number of subjects: 199
Study: 22683042

Group type: EXPERIMENTAL
Intervention: ERN/LRPT 1 g/20 mg/day from 0 to 4 weeks and then ERN/LRPT 2 g/40 mg/day from 5 to 32 weeks
Number of subjects: 1152

Group type: COMPARATOR
Intervention: ERN 2 g/day without LRPT from 21 to 32 weeks
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo for the entire study
Number of subjects: 1152
Study: 20725588

Group type: EXPERIMENTAL
Intervention: Insulin glargine (IG; Lantus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin detemir (ID; Levemir)
Number of subjects: 0
Study: 18523643

Group type: EXPERIMENTAL
Intervention: bivalent killed whole cell oral cholera vaccine
Number of subjects: 201

Group type: COMPARATOR
Intervention: placebo (killed oral Escherichia coli K12)
Number of subjects: 201
Study: 15841627

Group type: EXPERIMENTAL
Intervention: S‐Caine Peel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15543446

Group type: EXPERIMENTAL
Intervention: Virtual obstacle training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Real obstacle training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both training methods
Number of subjects: 20